Characterisation of recombinant glycosylation variants of insulin-like growth factor binding protein-3

被引:87
作者
Firth, SM [1 ]
Baxter, RC [1 ]
机构
[1] Royal N Shore Hosp, Kolling Inst Med Res, St Leonards, NSW 2065, Australia
关键词
D O I
10.1677/joe.0.1600379
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Then are three potential N-glycosylation sites in the non-conserved central region of the insulin-like growth factor binding protein-3 (IGFBP-3) sequence (N(89)AS, N(109)AS, (NFS)-F-172). IGFBP-3 exists as two glyco-forms which reduce to a single form on enzymatic deglycosylation. To determine the functional significance of the carbohydrate chains, the N-glycosylation sites were mutated singly and in combinations by substituting Asn residues with Ala. Each recombinant glycoform was detected by radioimmunoassay, indicating that glycosylation is not essential for secretion in Chinese hamster ovary cells. Ligand blotting of the conditioned media using [I-125]IGF-I indicated that all seven mutants are active. On the basis of the number and molecular masses of the: bands detected for each glycoform, there is approximately 4, 4.5 and 5 kDa of carbohydrate on Asn(89), Asn(109) and Asn(172) respectively, with variable occupancy of Asn(172). Ternary complex formation by the glycovariants in the: presence of ALS and excess IGF-I was not significantly different from that of fully glycosylated recombinant human (rh)IGFBP-3 [K-a (fully glycosylated)= 12.5 +/- 4.1 l/nmol; mean K-a (all mutants) = 22.1 +/- 3.0 l/nmol]. In contrast, Asn to Asp substitutions decreased acid-labile subunit (ALS) binding activity. Cell-surface association experiments indicate that glycosylation may influence the partitioning of IGFBP-3 between the extracellular milieu and the cell surface. Therefore, while the carbohydrate units appear to be non-essential to ALS or IGF binding, they may modulate other biological activities of IGFBP-3.
引用
收藏
页码:379 / 387
页数:9
相关论文
共 35 条
[1]   A NEW-GENERATION OF INFORMATION-RETRIEVAL TOOLS FOR BIOLOGISTS - THE EXAMPLE OF THE EXPASY WWW SERVER [J].
APPEL, RD ;
BAIROCH, A ;
HOCHSTRASSER, DF .
TRENDS IN BIOCHEMICAL SCIENCES, 1994, 19 (06) :258-260
[2]   HUMAN INSULIN-LIKE GROWTH-FACTOR BINDING PROTEIN-6 IS O-GLYCOSYLATED [J].
BACH, LA ;
THOTAKURA, NR ;
RECHLER, MM .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1992, 186 (01) :301-307
[4]  
BAXTER RC, 1989, J BIOL CHEM, V264, P11843
[5]  
BAXTER RC, 1992, J BIOL CHEM, V267, P60
[6]   RADIOIMMUNOASSAY OF GROWTH-HORMONE DEPENDENT INSULIN-LIKE GROWTH-FACTOR BINDING-PROTEIN IN HUMAN-PLASMA [J].
BAXTER, RC ;
MARTIN, JL .
JOURNAL OF CLINICAL INVESTIGATION, 1986, 78 (06) :1504-1512
[7]  
BAXTER RC, 1989, P NATL ACAD SCI USA, V86, P6896
[8]   DIFFERENTIAL-EFFECTS OF INSULIN-LIKE GROWTH-FACTOR (IGF)-I AND IGF-II ON THE EXPRESSION OF IGF BINDING-PROTEINS (IGFBPS) IN A RAT NEUROBLASTOMA CELL-LINE - ISOLATION AND CHARACTERIZATION OF 2 FORMS OF IGFBP-4 [J].
CEDA, GP ;
FIELDER, PJ ;
HENZEL, WJ ;
LOUIE, A ;
DONOVAN, SM ;
HOFFMAN, AR ;
ROSENFELD, RG .
ENDOCRINOLOGY, 1991, 128 (06) :2815-2824
[9]   HIGH-FREQUENCY TRANSFECTION OF CHO CELLS USING POLYBRENE [J].
CHANEY, WG ;
HOWARD, DR ;
POLLARD, JW ;
SALLUSTIO, S ;
STANLEY, P .
SOMATIC CELL AND MOLECULAR GENETICS, 1986, 12 (03) :237-244
[10]   REGULATION AND BIOLOGICAL EFFECT OF ENDOGENOUS INSULIN-LIKE GROWTH-FACTOR BINDING PROTEIN-5 IN HUMAN OSTEOBLASTIC CELLS [J].
CONOVER, CA ;
KIEFER, MC .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1993, 76 (05) :1153-1159